Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · IEX Real-Time Price · USD
7.63
-0.41 (-5.10%)
At close: Apr 25, 2024, 4:00 PM
7.81
+0.18 (2.36%)
After-hours: Apr 25, 2024, 7:39 PM EDT
Vir Biotechnology Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Vir Biotechnology stock have an average target of 33.29, with a low estimate of 10 and a high estimate of 110. The average target predicts an increase of 336.30% from the current stock price of 7.63.
Analyst Consensus: Buy
* Price targets were last updated on Mar 15, 2024.
Analyst Ratings
The average analyst rating for VIR stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $110 | Strong Buy | Reiterates | $110 | +1,341.68% | Mar 15, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $9 → $10 | Hold | Maintains | $9 → $10 | +31.06% | Feb 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $85 → $110 | Strong Buy | Maintains | $85 → $110 | +1,341.68% | Feb 14, 2024 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $23 → $9 | Buy → Hold | Downgrades | $23 → $9 | +17.96% | Jan 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $95 → $85 | Strong Buy | Maintains | $95 → $85 | +1,014.02% | Jan 23, 2024 |
Financial Forecast
Revenue This Year
41.78M
from 86.18M
Decreased by -51.52%
Revenue Next Year
42.03M
from 41.78M
Increased by 0.59%
EPS This Year
-4.13
from -4.59
EPS Next Year
-4.02
from -4.13
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 127.9M | 111.5M | 144.9M | 803.0M | 1.5B |
| Avg | 41.8M | 42.0M | 62.1M | 298.6M | 738.7M |
| Low | 22.2M | 17.3M | 24.5M | 39.2M | 39.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 48.4% | 166.9% | 244.8% | 1,193.9% | 400.4% |
| Avg | -51.5% | 0.6% | 47.7% | 381.1% | 147.4% |
| Low | -74.2% | -58.5% | -41.7% | -36.8% | -86.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -3.60 | -2.97 | -1.97 | -2.95 |
| Avg | -4.13 | -4.02 | -3.67 | -2.84 |
| Low | -4.84 | -5.55 | -6.24 | -2.75 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | - |
| Avg | - | - | - | - |
| Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.